海外の治験の状況「脳卒中」での検索結果
122件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A Phase I/II safety and tolerability study following autologous infusion of adult haematopoietic cells to patients with acute total anterior circulation ischaemic stroke
- Acute Total Anterior Circulation Ischaemic Stroke
- United Kingdom
- 2006-04-10
Authorised
- Imatinib Treatment in Acute Ischemic Stroke
- Acute ischaemic stroke;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Sweden
- 2010-05-27
Authorised
- Study of clot dissolving treatment for stroke that occurs during sleep
- Acute ischaemic stroke upon awakening ("wake-up stroke") br>MedDRA version: 20.0 Level: LLT Classification code 10055221 Term: Ischemic stroke System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Denmark, Finland, Lithuania, United Kingdom
- 2016-05-24
Authorised
- Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of OSU6162 in the treatment of residual symptoms after stroke
- Stroke;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Sweden
- 2017-01-03
Authorised
- A Phase 1b/2 study to assess the safety, pharmacokinetics, and pharmacodynamics of DS-1040B in subjects with acute ischemic stroke.
- DS-1040b is an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor (TAFIa) intended to be used for the treatment of thrombotic diseases including acute ischemic stroke (AIS).;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Czech Republic, France, Germany, Italy, Slovakia, Spain, United Kingdom, United States
- 2015-06-29
Authorised
- Study to evaluate safety and effectiveness of NA-1 in reducing disability in stroke patients selected for mechanical clot removal procedures.
- Acute Ischemic Stroke (AIS) in adult subjects with a large intracranial arterial occlusion, a small ischemic core, and good collaterals. MedDRA version: 20.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10055221 Term: Ischemic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: LLT Classification code 10023027 Term: Ischaemic stroke NOS System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10074321 Term: Nonhaemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10074318 Term: Nonhemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Canada, Germany, Ireland, Korea, Republic of, Sweden, United Kingdom, United States
- 2017-12-18
Authorised
- ESTABLISHING THE EFFECT(S) AND SAFETY OF FLUOXETINE IN NON-DEPRESSED STROKE PATIENTS INITIATED IN THE ACUTE PHASE OF STROKE
- Cerebrovascular diseases;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Sweden
- 2014-06-16
Authorised
- Rapid Intervention with GTN in Hypertensive stroke Trial (RIGHT). Determining the potential of ambulance-based randomised controlled trials in patients with hyperacute stroke; assessment of glyceryl trinitrate in lowering blood pressure. - RIGHT
- Hypertension in acute stroke br>MedDRA version: 9.1 Level: LLT Classification code 10020772 Term: Hypertension
- United Kingdom
- 2008-02-01
Authorised
- Dabigatran etexilate for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
- A study to compare dabigatran etexilate to acetylsalicylic acid in preventing recurrent stroke for patients that already had a stroke caused by an embolus (clot). Despite testing, it is unknown where in the body the embolus developed. MedDRA version: 18.1 Level: PT Classification code 10067167 Term: Cerebellar embolism System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1 Level: PT Classification code 10014498 Term: Embolic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1 Level: PT Classification code 10060839 Term: Embolic cerebral infarction System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1 Level: PT Classification code 10074422 Term: Brain stem embolism System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Estonia, European Union, France, Germany, Greece, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Peru, Poland, Portugal, Russian Federation, Serbia, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, Taiwan, Thailand, United States
- 2014-09-05
Authorised
- Influence of long-term administration of fluoxetine on cerebral threshold and muscle activity patterns in chronic stroke patients. - Influence of fluoxetine on brain and muscle activity in chronic stroke patients
- The effect of fluoxetine on brain excitability and muscle activation will be measured in chronic stroke patients (> 6 months after stroke). As secondary measures, also brain activation, phase-synchronization in the brain, and motor function will be studied. MedDRA version: 8.1 Level: LLT Classification code 10055221 Term: Ischemic stroke
- Netherlands
- 2006-11-10
